Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      USIBC urges govt to ease regulatory curbs on APIs, medical devices

      USIBC urges govt to ease regulatory curbs on APIs, medical devices

      Medical Dialogues Bureau30 March 2020 2:58 PM IST
      US-India Business Council has written to Prime Minister Narendra Modi this week to suggested the Centre to "temporarily relax regulatory barriers that...
      Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung

      Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung

      Medical Dialogues Bureau30 March 2020 1:19 PM IST
      Zurich: Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's...
      Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

      Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

      Medical Dialogues Bureau30 March 2020 1:18 PM IST
      Mumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
      Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

      Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

      Medical Dialogues Bureau29 March 2020 1:32 PM IST
      Hertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
      NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

      NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

      Medical Dialogues Bureau29 March 2020 1:19 PM IST
      New Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
      Novartis, Life sciences companies commit to fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation

      Novartis, Life sciences companies commit to fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation

      Medical Dialogues Bureau29 March 2020 12:19 PM IST
      Basel: Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture, and...
      Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients

      Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients

      Medical Dialogues Bureau29 March 2020 12:15 PM IST
      Venclexta/Venclyxto is being developed by AbbVie and Roche.
      USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema

      USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema

      Medical Dialogues Bureau29 March 2020 11:27 AM IST
      AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects
      Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

      Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

      Medical Dialogues Bureau28 March 2020 1:30 PM IST
      Hertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
      Philips to ramp up production of ventilators in coronavirus fight

      Philips to ramp up production of ventilators in coronavirus fight

      Medical Dialogues Bureau28 March 2020 1:00 PM IST
      Amsterdam: Dutch health technology company Philips is to ramp up production of critical healthcare products to help diagnose and treat patients with...
      Prophylaxis effect of hydroxychloroquine in COVID-19:  Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota research

      Prophylaxis effect of hydroxychloroquine in COVID-19: Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota research

      Medical Dialogues Bureau28 March 2020 12:52 PM IST
      The trial is being led by internationally recognized infectious disease expert David Boulware, MD, MPH and his research team among 1,500 healthcare...
      With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19

      With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19

      Medical Dialogues Bureau28 March 2020 12:09 PM IST
      Abbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok